HORIZON ORPHAN LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 36219
 
  
 
C07K PEPTIDES 9127
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 689
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 544
 
  
 
C07D HETEROCYCLIC COMPOUNDS 2160
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
A01P BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS 114
 
  
 
B01D SEPARATION 1133
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0002,004 ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOFJul 05, 16Jan 05, 17[C07D, C07C]
2016/0279,138 AEROSOLIZED FLUOROQUINOLONES AND USES THEREOFJun 03, 16Sep 29, 16[A61K]
2016/0243,082 4-Methylpyrazole Formulations for Inhibiting Ethanol IntoleranceMay 02, 16Aug 25, 16[A61K]
2016/0128,954 Methods of Treating Huntington's Disease Using Cysteamine CompositionsNov 05, 15May 12, 16[A61K]
2015/0125,526 Use of Cysteamine and Derivatives Thereof to Treat Mitochondrial DiseasesNov 06, 14May 07, 15[A61K]
2012/0035,166 METHODS OF TREATING A PULMONARY BACTERIAL INFECTION USING FLUOROQUINOLONESOct 21, 11Feb 09, 12[A01P, A61K, A01N, A61P]
2011/0189,084 Method for Treating Liver Disorders with Receptor Associated Protein (RAP) Peptide-Fucosidase Inhibitor ConjugatesJan 28, 11Aug 04, 11[A61K, A61P, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9879064 Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereofJun 23, 15Jan 30, 18[A61K, C07K]
9717738 Aerosol fluoroquinolone formulations for improved pharmacokineticsApr 18, 16Aug 01, 17[A61K, A61P]
9700564 Use of aerosolized levofloxacin for treating cystic fibrosisMar 05, 12Jul 11, 17[A61K]
9435785 Methods for analyzing cysteamine compositionsJun 17, 14Sep 06, 16[G01N, B01D]
9326936 Aerosol fluoroquinolone formulations for improved pharmacokineticsJul 17, 14May 03, 16[A61K, A61P]
9326971 4-methylpyrazole formulations for inhibiting ethanol intoleranceFeb 05, 14May 03, 16[A61K]
9233077 Delayed release cysteamine bead formulation, and methods of making and using sameJun 17, 14Jan 12, 16[A61K]
9173850 4-methylpyrazole formulationsDec 06, 10Nov 03, 15[A61K]
9173851 Delayed release cysteamine bead formulation, and methods of making and using sameJun 26, 15Nov 03, 15[A61K]
9062126 Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereofSep 18, 06Jun 23, 15[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0007,578 Genotype Specific Methods for Treating Human Subjects Using 4-MethylpyrazoleAbandonedSep 20, 16Jan 12, 17[A61K]
2016/0341,706 Methods for Analyzing Cysteamine CompositionsAbandonedAug 05, 16Nov 24, 16[G01N]
2016/0331,704 Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using SameAbandonedJul 26, 16Nov 17, 16[A61K]
2016/0158,170 Delayed Release Cysteamine Bead Formulation, And Methods Of Making And Using SameAbandonedFeb 12, 16Jun 09, 16[A61K]
2016/0151,332 4-Methylpyrazole FormulationsAbandonedOct 30, 15Jun 02, 16[A61K]
2016/0095,827 DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAMEAbandonedDec 11, 15Apr 07, 16[A61K]
2014/0105,985 TOPICAL USE OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATIONAbandonedDec 19, 13Apr 17, 14[A61K]
2014/0066,441 AEROSOLIZED FLUOROQUINOLONES AND USES THEREOFAbandonedAug 28, 13Mar 06, 14[A61K]
2013/0150,419 4-METHYLPYRAZOLE FORMULATIONS FOR INHIBITING ETHANOL INTOLERANCEAbandonedFeb 01, 13Jun 13, 13[A61K]
2012/0322,843 GENOTYPE SPECIFIC METHODS FOR TREATING HUMAN SUBJECTS USING 4-METHYLPYRAZOLEAbandonedJun 21, 12Dec 20, 12[A61K, A61P]
2012/0252,857 GENOTYPE SPECIFIC METHODS FOR TREATING HUMAN SUBJECTS USING 4-METHYLPYRAZOLEAbandonedJun 09, 10Oct 04, 12[A61K, A61P]
2011/0053,999 4-METHYLPYRAZOLE FORMULATIONS FOR INHIBITING ETHANOL INTOLERANCEAbandonedJun 09, 10Mar 03, 11[A61K, A61P]
2008/0021,083 4-Methylpyrazole Formulations for Inhibiting Ethanol IntoleranceAbandonedMar 03, 05Jan 24, 08[A61K, C07D, A61P]
2005/0026,823 Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissuesAbandonedJun 20, 03Feb 03, 05[A61K, C07K]
2003/0129,186 Compositions and methods for modulating blood-brain barrier transportAbandonedJul 25, 02Jul 10, 03[A61K, G01N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.